- Home
- EQBK vs PRCT Comparison
EQBK vs PRCT Comparison
Compare EQBK & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EQBK | PRCT |
|---|---|---|
| Founded | 2002 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EQBK | PRCT |
|---|---|---|
| Price | $48.68 | $17.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $51.33 | $35.44 |
| AVG Volume (30 Days) | 73.7K | ★ 1.1M |
| Earning Date | 04-14-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.59% | N/A |
| EPS Growth | N/A | ★ 1.71 |
| EPS | ★ 2.06 | N/A |
| Revenue | N/A | ★ $308,054,000.00 |
| Revenue This Year | $74.58 | $31.34 |
| Revenue Next Year | $5.11 | $24.52 |
| P/E Ratio | $23.38 | ★ N/A |
| Revenue Growth | N/A | ★ 37.22 |
| 52 Week Low | $38.60 | $16.67 |
| 52 Week High | $52.27 | $38.11 |
Technical Indicators
Market Signals| Indicator | EQBK | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 43.05 | 33.27 |
| Support Level | $48.53 | $16.89 |
| Resistance Level | $51.93 | $29.27 |
| Average True Range (ATR) | 1.05 | 0.94 |
| MACD | -0.15 | -0.35 |
| Stochastic Oscillator | 31.06 | 4.26 |
Price Performance
Historical ComparisonAbout EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 77 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.